These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Etiology of neural tube defects and possible means of prevention]. Braun HS; Steinbicker V Beitr Orthop Traumatol; 1983 Apr; 30(4):169-72. PubMed ID: 6870755 [No Abstract] [Full Text] [Related]
44. Etiology, pathogenesis and prevention of neural tube defects. Padmanabhan R Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763 [TBL] [Abstract][Full Text] [Related]
45. Folic acid to prevent neural tube defects: scientific advances and public health issues. Mills JL; Conley MR Curr Opin Obstet Gynecol; 1996 Dec; 8(6):394-7. PubMed ID: 8979009 [TBL] [Abstract][Full Text] [Related]
47. [A clinico-epidemiological study of neural tube defects in newborn infants]. Kalaĭdzhieva M; Popivanova A; Doĭcheva E; Shishkova R; Nikolov A; Dimitrov A Akush Ginekol (Sofiia); 2000; 39(2):16-9. PubMed ID: 10948613 [TBL] [Abstract][Full Text] [Related]
48. Maternal serum triple analyte screening in pregnancy. Graves JC; Miller KE; Sellers AD Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965 [TBL] [Abstract][Full Text] [Related]
49. Fortification of food with folic acid and the prevention of neural tube defects. Bower C N Z Med J; 2003 Jan; 116(1168):U292. PubMed ID: 12601417 [No Abstract] [Full Text] [Related]
50. [Preconception consultation: a good idea?]. Schaapveld K Ned Tijdschr Geneeskd; 1995 May; 139(20):1045-6. PubMed ID: 7777088 [No Abstract] [Full Text] [Related]
51. California law requires offer of AFP test. Scheck A Ob Gyn News; 1986 Feb 15-28; 21(4):3, 26. PubMed ID: 11658662 [No Abstract] [Full Text] [Related]
52. Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum markers in Thai pregnant women. Wasant P; Liammongkolkul S Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():244-8. PubMed ID: 15906746 [TBL] [Abstract][Full Text] [Related]
54. [Use of ultrasonography of the skull in the fetus and the newborn infant]. Pinto Laso F; Ruiz Flores M Rev Chil Obstet Ginecol; 1983; 48(3):165-70. PubMed ID: 6398475 [No Abstract] [Full Text] [Related]
55. Recurrence risk after neural tube defects in a genetic counselling clinic. Czeizel A; Métneki J J Med Genet; 1984 Dec; 21(6):413-6. PubMed ID: 6512828 [TBL] [Abstract][Full Text] [Related]
56. Folic acid to prevent recurrence of neural tube defects. Pearson K J Okla State Med Assoc; 1999 Oct; 92(10):513. PubMed ID: 10528476 [No Abstract] [Full Text] [Related]
58. [The primary prophylaxis of neural tube defects in the Podkarpacian region]. Perenc L; Mach-Jamińska A Przegl Lek; 2006; 63(8):606-9. PubMed ID: 17441366 [TBL] [Abstract][Full Text] [Related]
59. [Triple test: problem or enhancement of prenatal diagnosis]. Rauskolb R; Engel W Z Geburtshilfe Neonatol; 1995; 199(3):91. PubMed ID: 7553260 [No Abstract] [Full Text] [Related]
60. Improving child and family health through primary prevention of neural tube defects. Schultz AW Pediatr Nurs; 1999; 25(4):419-22. PubMed ID: 12024361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]